Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Uvette Lou"'
Publikováno v:
Leukemialymphoma. 63(13)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7507028f32b92f2b485c1bb589798b7
https://pubmed.ncbi.nlm.nih.gov/36036363
https://pubmed.ncbi.nlm.nih.gov/36036363
Autor:
Uvette Lou, Lawrence S. Blaszkowsky, Vineet K. Raghu, Sean P. Murphy, John W. Clark, Zsofia D. Drobni, Erica Tavares, Ramya C. Mosarla, Hannah K Gilman, Raza M. Alvi, Maeve Jones-O'Connor, Tomas G. Neilan, Colin D. Weekes, Sarah Hartmann, Amna Zafar, Matthew Lei, Jeffrey W. Clark
Publikováno v:
JACC: CardioOncology. 3:101-109
Background Coronary vasospasm is a recognized side effect of 5-fluorouracil (5-FU). There are limited and conflicting data on the incidence, risk factors, and prognostic effect of 5-FU–associated vasospasm. Objectives This study sought to assess th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f9357517e3c6ade4d2358c6d6206df5
https://doi.org/10.1016/j.jaccao.2020.12.005
https://doi.org/10.1016/j.jaccao.2020.12.005
Autor:
Uvette Lou, Matthew M Lei, Mark Sorial, Daniel Lage, Kenechukwu Aniagboso, Emily Buttermore, Margaret Soriano, Ryan D. Nipp, Patrick Connor Johnson
Publikováno v:
Blood. 140:13088-13089
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba2ab0139e651a17566828fdf2fb6177
https://doi.org/10.1182/blood-2022-168129
https://doi.org/10.1182/blood-2022-168129
Publikováno v:
JCO Oncology Practice. 16:5-14
The treatment of multiple myeloma (MM) continues to evolve with the approval of numerous agents over the past decade. Advances in treatment have led to the incorporation of these newer therapies into the treatment paradigm, with improvements in overa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603c74910cae087016a16e6a985f025d
https://doi.org/10.1200/jop.19.00244
https://doi.org/10.1200/jop.19.00244
Publikováno v:
Blood. 136:14-16
Background Hypercalcemia (HC) is a frequent complication of multiple myeloma (MM) occurring in 20-30% of patients. This is often associated with renal dysfunction and both features are important myeloma defining events resulting in significant morbid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::896a71aaff6a57ed2785a9b6fe14ecbe
https://doi.org/10.1182/blood-2020-140702
https://doi.org/10.1182/blood-2020-140702
Publikováno v:
J Clin Pharmacol
High-dose methotrexate (HDMTX) is a commonly used treatment for hematologic malignancies involving the central nervous system. Two case reports described possible delayed methotrexate clearance in patients receiving concurrent levetiracetam, while a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fffccd9ab4d51be70ba9f9b78e357aa9
https://doi.org/10.1002/jcph.1544
https://doi.org/10.1002/jcph.1544
Publikováno v:
Journal of Oncology Pharmacy Practice. 25:1860-1866
Purpose Urinary alkalinization with intravenous sodium bicarbonate is standard during high-dose methotrexate administration. Due to a national intravenous sodium bicarbonate shortage, a urinary alkalinization protocol involving hyperhydration with in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bde8229c0826fa8dd3a23eed9cf18740
https://doi.org/10.1177/1078155218821406
https://doi.org/10.1177/1078155218821406
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(1)
Background Studies evaluating antiemetic prophylaxis have primarily focused on the solid tumor setting and single-day regimens. This study evaluates antiemetic prophylaxis and chemotherapy induced nausea and vomiting (CINV) in patients with lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c5d7937e172761205055034ccdc312
https://pubmed.ncbi.nlm.nih.gov/33435826
https://pubmed.ncbi.nlm.nih.gov/33435826
Autor:
Sean M. Murphy, Jeffrey W. Clark, Hannah K Gilman, Raza M. Alvi, Colin D. Weekes, Ramya C. Mosarla, Zsofia D. Drobni, Erica Tavares, John W. Clark, Amna Zafar, Matthew Lei, Maeve Jones-O'Connor, Sarah Hartmann, Lawrence S. Blaszkowsky, Ryan D. Nipp, ali mahmood, Tomas G. Neilan, Uvette Lou
Publikováno v:
Circulation. 142
Introduction: Coronary vasospasm is a side effect of 5-FU (fluorouracil). Beyond switching chemotherapy regimens, there are no established treatments for vasospasm. Limited data exist regarding the efficacy of calcium channel blockers (CCBs) and/or n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83a621eee530e7d90eb3bd1758801d54
https://doi.org/10.1161/circ.142.suppl_3.16787
https://doi.org/10.1161/circ.142.suppl_3.16787
Autor:
Matthew Lei, Ryan David Nipp, Erica Tavares, Uvette Lou, Erica Grasso, Stephanie Y Mui, Jan Peter Marquardt, Till D. Best, Emily E. Van Seventer, Anurag Saraf, Ismail Tahir, Nora K. Horick, Florian J. Fintelmann, Eric Roeland
Publikováno v:
Journal of Clinical Oncology. 40:84-84
84 Background: We evaluated the impact of baseline sarcopenia on hematologic toxicity, treatment intensity, and healthcare utilization in patients with mCRC receiving FOLFOX or FOLFIRI. Methods: We retrospectively analyzed patients with mCRC who rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a534ecdfac589373358b357a8128c09
https://doi.org/10.1200/jco.2022.40.4_suppl.084
https://doi.org/10.1200/jco.2022.40.4_suppl.084